PINK:CBIA

Canopus Biopharma Stock Signals

> Shell Companies

Buy CBIA

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 23, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Canopus Biopharma, Inc.

General

	Signal Type	Signal Value	Data
	Score	0.000	34 days ( 0 %
	Last Price	$0.0001	0 %
Performance History 7 Days $0.0001 $0.0001 0% 30 Days $0.0001 $0.0001 0% 12 Mos $0.0001 $0.0001 0%

4/18

Active Buy Signals

Premium Feature

Specific Signals

Short Term

Net score: 39.86

Signal Type	Signal Value	Importance	Data
High / Low	N/A	Very Low	$0.0001 - $0.0001
Trend - 3 mos	0.00000011607143 %	High	Width: 0.00000293658812 %
Pred. range - 3 mos	$0.00009999999720 - $0.0001	Low	-0.00000280155558 % - 0.00000013503144 %
Volume Direction	Sell	High	Volume: 3 · Direction: 0
Pivot Short	Sell	Very Low	Jun 22, 2026 - 2 days
RSI Short Pivot Signal	Sell	Very Low	Nov 30, -0001 - N/A days
Short MA 3 mos	Sell	Low	Nov 30, -0001 - N/A days
Long MA 3 mos	Sell	Medium	Nov 30, -0001 - N/A days
Short/Long MA 3 mos	Buy	Medium	Apr 28, 2026 - 39 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now

Long Term

Net score: 40.16

Signal Type	Signal Value	Importance	Data
Trend - 12 mos	9.59 %	Very High	Width: 1,902.19 %
Pred. range - 12 mos	$0.00000595929253 - $0.0001	High	-94.04 % - 19.32 %
Short MA 12 mos	Sell	Very High	Jan 13, 2026 - 111 days
Long MA 12 mos	Sell	Very High	Jan 13, 2026 - 111 days
Short/Long MA 12 mos	Buy	Very High	Jan 20, 2026 - 107 days
Pivot Long	Sell	Low	Jun 22, 2026 - 2 days
RSI Long Pivot Signal	Sell	Low	Feb 19, 2026 - 86 days
Bollinger	Sell	Medium	Nov 30, -0001 - N/A days
MACD	Neutral	High	No Dates Stored For This Signal

Notice: Technical analysis is hidden due to insufficient data.

There can be multiple reasons for our algorithm to not provide conclusion. One of them can be low or no liquidity.

If you think this is not correct, please

ABOUT CANOPUS BIOPHARMA, INC.

Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporate...

Read Full Profile Here